Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$0.47
NASDAQLPCN
Open
$0.48
Change
$0.02 (5.05%)
Day's Range
$0.44 - $0.49
52-Week Range
$0.31 - $3.46
Volume
1.5M
Market Cap
$22.5M